Inc. ("bluebird") today confirmed it has received an unsolicited non-binding written proposal (the "Ayrmid Proposal") from Ayrmid Ltd ("Ayrmid") to acquire bluebird for an upfront cash payment of ...

Can generative AI (gen AI) rip things apart and then try to glue it all back together with more insight, more intelligence, more efficiency, and more value? It really depends on what the application ...

Saurabh Gandhi is Business Intelligence Senior Engineering Manager with 18 years of experience in transforming complex data ...

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing ...

Zimislecel, Vertex’s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the ...

Vertex Pharmaceuticals will not advance clinical trials of a treatment for Type 1 diabetes after efficacy data failed to support further clinical advancement.